Hematologic Malignancy
Primary Amyloidosis
CI-CAN-00008290Explore in graph →
HematologicNon-malignant32 active trials
- NCIt
- C3819
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00008290Explore in graph →
Clinical trials
106 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05776940 | Probiotic Supplementation Reduces Gastrointestinal Symptoms During the Therapy and Improves Therapeutic Response in AL Amyloidosis | unknown | Phase 3 | 116 | Air Force Military Medical University, ChinaOTHER | 0 | Mar 20, 2023 | clinicaltrials |
Data updated 22 days agoSource updated Mar 20, 2023source: clinicaltrials